ISRG
62
3
ILMN
27
2
SE
71
3
WHR
50
3
WAT
48
5
GPC
51
3
RL
69
19
ROST
54
7
GME
63
3
HRB
52
2
AN
46
5
CCL
60
2
HAL
54
7
APH
70
6
MRK
38
-2
EBAY
43
-9
CMG
48
5
DOV
64
5
PCAR
31
3
UAL
74
10
ISRG
62
3
ILMN
27
2
SE
71
3
WHR
50
3
WAT
48
5
GPC
51
3
RL
69
19
ROST
54
7
GME
63
3
HRB
52
2
AN
46
5
CCL
60
2
HAL
54
7
APH
70
6
MRK
38
-2
EBAY
43
-9
CMG
48
5
DOV
64
5
PCAR
31
3
UAL
74
10
Financhill
Back

Bruker Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
21

BRKR
Bruker

Last Price:
$43.23
Seasonality Move:
3.88%
Buy
60

ALNY
Alnylam Pharmaceuticals

Last Price:
$280.77
Seasonality Move:
3.3%
Sell
21
Bruker (BRKR) is a Sell

Is Bruker a Buy, Sell or Hold?

  • The current Bruker [BRKR] share price is $44.50. The Score for BRKR is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • BRKR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BRKR Stock Price Chart

What is Bruker's stock price today?

  • The Bruker share price today is $44.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRKR is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $290.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

BRKR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.09 Sell
Relative Strength Index (14 RSI): 33.78 Sell
Chaikin Money Flow: -1103732 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.34 - 50.34) Sell
Bollinger Bands (100): (50.1 - 60.04) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.72 Buy
Relative Strength Index (14 RSI): 71.41 Buy
Chaikin Money Flow: -979016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.44 - 263) Buy
Bollinger Bands (100): (240.32 - 271.8) Buy

BRKR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.63 Sell
20-day SMA: 46.98 Sell
50-day SMA: 52.58 Sell
200-day SMA: 59.82 Sell
8-day EMA: 45.51 Sell
20-day EMA: 47.24 Sell
50-day EMA: 50.97 Sell
200-day EMA: 59.44 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 257.74 Buy
20-day SMA: 249.75 Buy
50-day SMA: 257.54 Buy
200-day SMA: 251.5 Buy
8-day EMA: 263.89 Buy
20-day EMA: 256.08 Buy
50-day EMA: 255.39 Buy
200-day EMA: 243.44 Buy

Bruker Earnings Growth & BRKR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.29 per share, and an increase next year of $0.44 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Bruker Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):